New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 28, 2013
07:16 EDTECYT, SGENEndocyte added to Top Picks list; Seattle Genetics removed at Credit Suisse
Credit Suisse added Endocyte to the Top Picks list based on vintafolide regulatory and clinical events over the next 12 months, a strong cash position, and asset ownership, among other reasons.
News For ECYT;SGEN From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
July 30, 2015
16:20 EDTSGENSeattle Genetics sees FY15 Adcetris net product sales $210M-$220M
Subscribe for More Information
16:18 EDTSGENSeattle Genetics reports Q2 EPS (38c), consensus (26c)
Reports Q2 revenue $77.1M, consensus $77.97M.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use